Evidence map›Paper›PMID 35871231›Full record

ArticleCell death and differentiation2023

UFL1 promotes antiviral immune response by maintaining STING stability independent of UFMylation.

Yijie Tao, Shulei Yin, Yang Liu, Chunzhen Li, Yining Chen, Dan Han, Jingyi Huang, Sheng Xu, Zui Zou, Yizhi Yu

Open access · hybridAbstract read
In one paragraph

Article in Cell death and differentiation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. cGAS-STING as a Neuroimmune Traffic Molecule: Unraveling Pathogenic Mechanisms and Therapeutic Potential in Neurological Disorders.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Phytochemical small molecules fromAmerican journal of translational research · 2026
    Review
  14. Targeting ubiquitination in disease and therapy.Signal transduction and targeted therapy · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Yijie Tao *National Key Laboratory of Medical Immunology and Institute of Immunology, Naval Medical University, Shanghai, 200433, China.
Shulei Yin *National Key Laboratory of Medical Immunology and Institute of Immunology, Naval Medical University, Shanghai, 200433, China.
Yang Liu *Department of Anesthesiology, Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai, 200003, China.
Chunzhen LiNational Key Laboratory of Medical Immunology and Institute of Immunology, Naval Medical University, Shanghai, 200433, China.
Yining ChenNational Key Laboratory of Medical Immunology and Institute of Immunology, Naval Medical University, Shanghai, 200433, China.
Dan HanNational Key Laboratory of Medical Immunology and Institute of Immunology, Naval Medical University, Shanghai, 200433, China.
Jingyi HuangNational Key Laboratory of Medical Immunology and Institute of Immunology, Naval Medical University, Shanghai, 200433, China.
Sheng XuNational Key Laboratory of Medical Immunology and Institute of Immunology, Naval Medical University, Shanghai, 200433, China. xusheng@immunol.org.ORCID 0000-0002-9547-8052
Zui ZouNational Key Laboratory of Medical Immunology and Institute of Immunology, Naval Medical University, Shanghai, 200433, China. zouzui@smmu.edu.cn.ORCID 0000-0002-8433-8388
Yizhi YuNational Key Laboratory of Medical Immunology and Institute of Immunology, Naval Medical University, Shanghai, 200433, China. yuyz@immunol.org.ORCID 0000-0002-3793-1154
Second Military Medical University · CNNaval Medical Research Command · USShanghai Changzheng Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The precise regulation of STING homeostasis is essential for its antiviral function. Post-translational modification, especially ubiquitination, is important for the regulation of STING homeostasis. Previous studies have focused on how STING is degraded, but little is known about its maintenance. Here, we show that UFM1 specific ligase UFL1 promotes innate immune response by maintaining STING expression independent of UFMylation. Mechanistically, UFL1 inhibits TRIM29 to interact with STING, thereby reducing its ubiquitination at K338/K347/K370 and subsequent proteasomal degradation. DNA virus infection reduces the UFL1 expression, which may promote STING degradation and facilitate viral expansion. Our study identifies UFL1 as a crucial regulator for the maintenance of STING stability and antiviral function, and provides novel insights into the mechanistic explanation for the immunological escape of DNA virus.

Indexed as

Antiviral AgentsUbiquitin-Protein LigasesImmunityImmunity, InnateProtein Processing, Post-TranslationalUbiquitinationAntiviral AgentsUbiquitin-Protein Ligases

Identifiers

PMID35871231
PMCPMC9883236
OpenAlexW4286697219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.